Grifols Sustainability Profile
Grifols, officially known as Grifols, S.A., is a global leader in the biopharmaceutical industry, headquartered in Barcelona, Spain (ES). Founded in 1940, the company has established a strong presence in key operational regions, including Europe, North America, and Latin America. Grifols specialises in the development of plasma-derived medicines, diagnostic solutions, and hospital products, with a commitment to improving patient health. The company is renowned for its innovative therapies, particularly in the treatment of rare and chronic diseases, setting it apart in a competitive market. Grifols has achieved significant milestones, including the expansion of its plasma collection network and advancements in immunology. With a robust market position, Grifols continues to be recognised for its contributions to healthcare, making it a trusted name in the biopharmaceutical sector.
DitchCarbon Score
How does Grifols's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Grifols's score of 78 is higher than 86% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Grifols's reported carbon emissions
In 2024, Grifols reported total greenhouse gas emissions of approximately 1,231,771,000 kg CO2e, with Scope 1 emissions at about 106,289,000 kg CO2e, Scope 2 emissions (market-based) at approximately 73,876,000 kg CO2e, and Scope 3 emissions reaching about 1,051,606,000 kg CO2e. The company has set ambitious targets to reduce its emissions, aiming for a 55% reduction in greenhouse gas emissions per production unit by 2030, compared to 2018 levels. Additionally, Grifols commits to reducing absolute Scope 1 and 2 emissions by 42% by 2030 from a 2022 baseline, and Scope 3 emissions from purchased goods and services, capital goods, fuel- and energy-related activities, and upstream transportation and distribution by 25% within the same timeframe. Grifols is also working towards achieving net-zero emissions by 2050 for Scope 1 and 2 emissions. These commitments are aligned with the Science Based Targets initiative (SBTi) and reflect the company's dedication to addressing climate change within the pharmaceutical and biotechnology sector.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Scope 1 | 85,532,000 | 00,000,000 | 000,000,000 | 00,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 00,000,000 | 000,000,000 | 000,000,000 |
| Scope 2 | 113,055,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 00,000,000 | 00,000,000 |
| Scope 3 | 64,761,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 0,000,000,000 | 0,000,000,000 | 000,000,000 | 0,000,000,000 |
How Carbon Intensive is Grifols's Industry?
How Carbon Intensive is Grifols's Location?
Grifols's Scope 3 Categories Breakdown
Grifols's Scope 3 emissions, which increased by 11% last year and increased significantly since 2015, demonstrating supply chain emissions tracking. The vast majority of their carbon footprint comes from suppliers and value chain emissions, representing the vast majority of total emissions under the GHG Protocol, with "Purchased Goods and Services" being the largest emissions source at 53% of Scope 3 emissions.
Top Scope 3 Categories
Grifols's Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Grifols has established climate goals through participation in recognized frameworks and target-setting initiatives. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
Frequently Asked Questions
Common questions about Grifols's sustainability data and climate commitments